MedPath

Fluocinolone Acetonide

Fluocinolone Acetonide Topical Solution USP, 0.01%

Approved
Approval ID

270961cf-7ccb-4291-be16-87ce3196b200

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 9, 2024

Manufacturers
FDA

Glasshouse Pharmaceuticals Limited Canada

DUNS: 203493598

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fluocinolone Acetonide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71428-002
Application NumberANDA209596
Product Classification
M
Marketing Category
C73584
G
Generic Name
Fluocinolone Acetonide
Product Specifications
Route of AdministrationTOPICAL
Effective DateJanuary 9, 2024
FDA Product Classification

INGREDIENTS (3)

ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
FLUOCINOLONE ACETONIDEActive
Quantity: 0.1 mg in 1 mL
Code: 0CD5FD6S2M
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Fluocinolone Acetonide - FDA Drug Approval Details